Clinical Trial Update: A Study to Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating detection of BRAF V600 mutation in cfDNA from plasma in participants with metastatic melanoma; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED